{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:45:16Z","timestamp":1760550316555},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"S2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1186\/s12911-017-0472-y","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T13:30:33Z","timestamp":1499175033000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A signal detection method for temporal variation of adverse effect with vaccine adverse event reporting system data"],"prefix":"10.1186","volume":"17","author":[{"given":"Yi","family":"Cai","sequence":"first","affiliation":[]},{"given":"Jingcheng","family":"Du","sequence":"additional","affiliation":[]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Susan S.","family":"Ellenberg","sequence":"additional","affiliation":[]},{"given":"Sean","family":"Hennessy","sequence":"additional","affiliation":[]},{"given":"Cui","family":"Tao","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,7,5]]},"reference":[{"key":"472_CR1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1994.tb05705.x","volume":"37","author":"N Baber","year":"1994","unstructured":"Baber N. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ich). Br J Clin Pharmacol. 1994;37:401\u20134.","journal-title":"Br J Clin Pharmacol"},{"key":"472_CR2","unstructured":"USA.gov, CDC, FDA. Vaccine Adverse Event Reporting System[internet]. CDC and FDA. Available from: https:\/\/vaers.hhs.gov\/data\/index ."},{"key":"472_CR3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"S Evans","year":"2001","unstructured":"Evans S, Waller PC, Davis S. Use of proportional reporting ratios (prrs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10:483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"472_CR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf. 2004;13:519\u201323.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"472_CR5","unstructured":"Greenwood PE, Nikulin MS. A guide to chi-squared testing. Hoboken, New Jersey. John Wiley & Sons; 1996. p. 280."},{"key":"472_CR6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1198\/jasa.2011.ap10243","volume":"106","author":"L Huang","year":"2011","unstructured":"Huang L, Zalkikar J, Tiwari RC. A likelihood ratio test based method for signal detection with application to FDA\u2019s drug safety data. J Am Stat Assoc. 2011;106:1230\u201341.","journal-title":"J Am Stat Assoc"},{"key":"472_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W DuMouchel","year":"1999","unstructured":"DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999;53:177\u201390.","journal-title":"Am Stat"},{"key":"472_CR8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards I, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54:315\u201321.","journal-title":"Eur J Clin Pharmacol"},{"key":"472_CR9","doi-asserted-by":"crossref","first-page":"D31","DOI":"10.1016\/j.vaccine.2008.07.078","volume":"26","author":"CA Russell","year":"2008","unstructured":"Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza virus. Vaccine. 2008;26:D31\u20134.","journal-title":"Vaccine"},{"key":"472_CR10","unstructured":"CDC. Key Facts About Seasonal Flu Vaccine [updated 2016 Oct 14; cited 2017 Feb 14]. Available from:\u00a0 https:\/\/www.cdc.gov\/flu\/protect\/keyfacts.htm ."},{"key":"472_CR11","unstructured":"CDC. Seasonal influenza vaccine supply and distribution in the United States. CDC. 2016 [updated 2016 Aug 22; cited 2017 Feb 14]. Available from: http:\/\/www.cdc.gov\/flu\/about\/qa\/vaxdistribution.htm ."},{"key":"472_CR12","unstructured":"CDC. 2016\u20132017 Flu season. CDC. 2016 [updated 2016 Nov 22; cited 2017 Feb 14]. Available from: https:\/\/www.cdc.gov\/flu\/about\/season\/current.htm ."},{"key":"472_CR13","unstructured":"CDC. Influenza vaccines \u2014 United States, 2016\u201317 influenza season. CDC. 2016 [updated 2016 Nov 22; cited 2017 Feb 14]. Available from: https:\/\/www.cdc.gov\/flu\/protect\/vaccine\/vaccines.htm ."},{"key":"472_CR14","unstructured":"Passport Health. Seasonal Flu Shots-Quadrivalent and Trivalent Options. Passport Health. 2017 [cited 2017 Feb 14]. Available from: https:\/\/www.passporthealthusa.com\/vaccinations\/seasonal-flu-shots-quadrivalent-and-trivalent-options\/ ."},{"key":"472_CR15","unstructured":"MedDRA. Introductory Guide MedDRA Version 14.0. MedDRA. 2011[updated 2011 Mar; cited 2017 Feb 14]. Available from: http:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_14_0_english.pdf ."},{"key":"472_CR16","unstructured":"MedDRA. Introductory Guide MedDRA Version 19.1. MedDRA. 2016[updated 2016 Sep; cited 2017 Feb 14]. Available from: http:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/intguide_19_1_english.pdf ."},{"key":"472_CR17","unstructured":"MedDRA. What\u2019s New MedDRA Version 18.0. MedDRA. 2015[updated 2015 Mar; cited 2017 Feb 14]. Available from: http:\/\/www.meddra.org\/sites\/default\/files\/guidance\/file\/whatsnew_18_0_english.pdf ."},{"key":"472_CR18","doi-asserted-by":"crossref","first-page":"6918","DOI":"10.1016\/j.vaccine.2012.08.057","volume":"30","author":"F Lievano","year":"2012","unstructured":"Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, Amin MA, Seminack MM, Vagie KA, Dana A, et al. Measles, mumps, and rubella virus vaccine (m-m-r ii): A review of 32\u00a0years of clinical and post marketing experience. Vaccine. 2012;30:6918\u201326.","journal-title":"Vaccine"},{"key":"472_CR19","volume-title":"NCBO web services and the development of semantic applications","author":"National Center for Biomedical Ontology (NCBO)","year":"2012","unstructured":"National Center for Biomedical Ontology (NCBO). NCBO web services and the development of semantic applications. 2012."},{"issue":"2","key":"472_CR20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/biomet\/84.2.309","volume":"84","author":"X Lin","year":"1997","unstructured":"Lin X. Variance component testing in generalized linear models with random effects. Biometrika. 1997;84(2):309\u201326.","journal-title":"Biometrika"},{"issue":"4","key":"472_CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/biomet\/78.4.719","volume":"78","author":"R Schall","year":"1997","unstructured":"Schall R. Estimation in generalized linear models with random effects. Biometrika. 1997;78(4):719\u201327.","journal-title":"Biometrika"},{"key":"472_CR22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/biomet\/asq031","volume":"97","author":"Y Chen","year":"2010","unstructured":"Chen Y, Liang K-Y. On the asymptotic behaviour of the pseudolikelihood ratio test statistic with boundary problems. Biometrika. 2010;97:603\u201320.","journal-title":"Biometrika"},{"key":"472_CR23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/biomet\/91.3.729","volume":"91","author":"DR Cox","year":"2004","unstructured":"Cox DR, Reid N. A note on pseudolikelihood constructed from marginal densities. Biometrika. 2004;91:729\u201337.","journal-title":"Biometrika"},{"key":"472_CR24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1090\/conm\/080\/999014","volume":"80","author":"BG Lindsay","year":"1988","unstructured":"Lindsay BG. Composite likelihood methods. Contemp Math. 1988;80:221\u201339.","journal-title":"Contemp Math"},{"key":"472_CR25","first-page":"5","volume":"21","author":"C Varin","year":"2011","unstructured":"Varin C, Reid N, Firth D. An overview of composite likelihood methods. Stat Sin. 2011;21:5\u201342.","journal-title":"Stat Sin"},{"key":"472_CR26","unstructured":"CDC. Timeline: thimerosal in vaccines (1999\u20132010). CDC. 2015 [updated 2015 Aug 28; cited 2017 Feb 14]. Available from: https:\/\/www.cdc.gov\/vaccinesafety\/concerns\/thimerosal\/timeline.html ."}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-017-0472-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T06:53:46Z","timestamp":1719298426000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-017-0472-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":26,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["472"],"URL":"https:\/\/doi.org\/10.1186\/s12911-017-0472-y","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]},"article-number":"76"}}